Disruptor Profile: Day Zero Diagnostics, Inc.

Research By Markets adds Market Research Report - Disruptor Profile: Day Zero Diagnostics, Inc.

For detailed information: https://www.researchbymarkets.com/report/disruptor-profile-day-zero-diagnostics-inc-406753.html

Disruptor Profile: Day Zero Diagnostics, Inc.

Summary

Day Zero Diagnostics Inc. is a medical technology company, which is developing a new class of diagnostics, including whole genome sequencing-based diagnostics, for modernizing the diagnosis and treatment of infectious disease using genome sequencing and machine learning (ML) technologies.

Scope

The report provides information and insights into Day Zero Diagnostics, Inc.’s, including –
– Overview of the company and its product offering
– Detailed insight into its business model, company type and headquarter
– Information on funding
– Biography of top management

Reasons to buy

– Gain insights into Day Zero Diagnostics Inc.’s business operations.
– Gain insights into fundings
– Gain understanding about its technology focus.

Companies Mentioned:
Sands Capital Ventures LLC
Golden Seeds LLC
TriVentures L.P.
National Institute of Allergies
Infectious Disease (NIAID)


For specific queries regarding this report: https://www.researchbymarkets.com/inquiry/406753

Contact Us:
ResearchByMarkets.com
Sales Desk
enquiry@researchbymarkets.com
USA: +1-800-416-3124
https://www.researchbymarkets.com/aboutus

Follow us on Social Media:
Facebook: https://www.facebook.com/researchbymarkets/
LinkedIn: https://www.linkedin.com/company/researchbymarkets/
Twitter: https://twitter.com/ResearchByMrkts

Market Research News brings the latest news and updates about the Industry.